NLRP4 and pancreatic neoplasm: Furthermore, the levels of intracellular ROS in NLRP4-knockdown pancreatic cancer cells and control cells treated with MitoQ remained unchanged, suggesting that NLRP4 triggers autophagy through ROS signaling.